A phase II trial of the aurora kinase A inhibitor MLN8237 in patients with metastatic castrate resistant and neuroendocrine prostate cancer Meeting Abstract
| Authors: | Beltran, H.; Rubin, M. A.; Mosquera, J. M.; Christos, P. J.; Calukovic, O.; Karpenko, I.; Pinski, J. K.; Danila, D. C.; Nanus, D. M.; Tagawa, S. T. |
| Abstract Title: | A phase II trial of the aurora kinase A inhibitor MLN8237 in patients with metastatic castrate resistant and neuroendocrine prostate cancer |
| Meeting Title: | 49th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 31 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2013 May 31-Jun 4 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2013-05-20 |
| Language: | English |
| ACCESSION: | WOS:000335419605459 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2013.31.15_suppl.tps5096 |
| Notes: | Meeting Abstract: TPS5096 -- Source: Wos |
